Cancer Therapy Market is estimated to be US$ 360.9 billion by 2030 with a CAGR of 8.9% during the forecast period
Cancer Therapy Market,
By Cancer Type (Breast Cancer, Prostate Cancer, Blood Cancer,
Gastrointestinal Cancer, Respiratory/Lung Cancer, Gynecologic Cancer, and Other
Cancer Types), By Treatment Type (Immunotherapy, Hormonal Therapy,
Chemotherapy, Targeted Therapy, and Other Treatment Types), By End User (Cancer
and Radiation Therapy Centers, Hospitals, and Specialty Clinics), and
Region - Global Forecast to 2030" global cancer
therapy market is projected to grow from US$ 66.5 billion in 2019 Certain
factors that are driving the market growth include increasing Patient
Assistance Programs (PAPs), increasing government initiatives for cancer
awareness, rising prevalence of cancer worldwide, and strong R&D
initiatives from key players. The upsurge in demand for personalized
medicine and high potential of developing nations is expected to provide new
opportunities for the market players in future.
Key
Highlights:
·
In January
2020, Medtronic Launches Efficio software to help clinicians efficiently manage
targeted drug delivery therapy with SynchroMed
·
In January
2020, Roche announced the completion of a supplemental Biologics License
Application (sBLA) submission to the US Food and Drug Administration (FDA) for
Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab),
for the treatment of people with unresectable hepatocellular carcinoma (HCC)
who have not received prior systemic therapy.
Key Market
Insights from the report:
The global
cancer therapy market accounted for US$ 66.5 billion in 2019 and is projected
to register a moderate CAGR of 8.50% over the forecast period. The market
report has been segmented on the cancer type, treatment type, end user,
and region.
·
By cancer
type, breast cancer is expected to dominate in this segment, due to higher
and continuously increasing prevalence of breast cancer across the world.
·
By treatment
type, the target therapy segment is dominating in this segment, due to its
specificity toward cancer cells, while sparing the toxicity to off-target
cells.
·
By end user,
the global cancer therapy market is sub-divided into cancer and radiation therapy centers, hospitals, and specialty
clinics.
·
By
region, North America is projected to
lead the global cancer therapy market and is expected to remain dominant during
the forecast period, owing to the increased
adoption of cancer therapy.
Before purchasing
this report, request a sample or make an inquiry by clicking the following
link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3768
The prominent
player operating in the global cancer therapy market includes Medtronic
Inc., F. Hoffman-La Roche Ltd., Universal Cancer Therapy Inc., LifeScan Inc.,
Abbott Point of Care Inc., Sysmex Corporation, Pharmaco-Kinesis Corporation
(PKC), Bio-Rad laboratories Inc., Cancer Therapy International Pte. Ltd., ACON
Laboratories, Inc., Nova Biomedical Corp.
About Prophecy
Market Insights
Prophecy Market Insights is
specialized market research, analytics, marketing/business strategy, and
solutions that offers strategic and tactical support to clients for making
well-informed business decisions and to identify and achieve high-value
opportunities in the target business area. We also help our clients to address
business challenges and provide the best possible solutions to overcome them
and transform their business.
To know more
Contact Us:
Sales
Prophecy Market Insights
Email- sales@prophecymarketinsights.com
Website- www.prophecymarketinsights.com

Comments
Post a Comment